Hostname: page-component-78c5997874-m6dg7 Total loading time: 0 Render date: 2024-11-16T09:24:30.151Z Has data issue: false hasContentIssue false
  • English
  • Français

Combinación de clozapina y maprotilina en la depresión psicótica rebelde al tratamiento

Published online by Cambridge University Press:  12 May 2020

M. Hrdlička
M. Hrdlička*
Affiliation:
Departamento de Psiquiatría, Universidad Carlos, Segunda Facultad de Medicina, Vuvalu 84, 15006, Praga, República Checa
Get access

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Informe Clínico
Information
European Psychiatry (Ed. Española) , Volume 10 , Issue 5 , June 2003 , pp. 337
Copyright
Copyright © European Psychiatric Association 2003

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

BIBLIOGRAFÍA

Chong, SA, Remington, G. Clozapine augmentation: safety and efficacy. Schizophr Bull 2000;26:421-40.CrossRefGoogle ScholarPubMed
Wahlbeck, K, Cheine, M, Essali, A, Adams, C. Evidence of clozapine’s effectiveness in schizophrenia: a systematic review and meta-analysis of randomized trials. Am J Psichiatry 1999;156:990-9.Google ScholarPubMed
Wheeler, JA, Mortimer, AM, Tyson, PJ. Somatic treatment of psychotic depression: review and recommendation for practice. J Clin Psychopharmacol 2000;20:504-19.CrossRefGoogle Scholar